-1||-1|-1||-1||nephrotoxicity||10029155
-1||-1|-1||-1||infusion-related reactions||10051792
-1||-1|-1||-1||clostridium difficile -associated diarrhea||10009657
-1||-1|-1||-1||diarrhea||10012735
-1||-1|-1||-1||taste disturbance||10013911
-1||-1|-1||-1||nausea||10028813
-1||-1|-1||-1||vomiting||10047700
-1||-1|-1||-1||foamy urine||-1
-1||-1|-1||-1||died||10011906
-1||-1|-1||-1||renal events||10038428
-1||-1|-1||-1||respiratory events||10075535
-1||-1|-1||-1||cardiac events||10075534
-1||-1|-1||-1||rash||10037844
-1||-1|-1||-1||rigors||10008531
-1||-1|-1||-1||decreased appetite||10061428
-1||-1|-1||-1||mortality||10011906
-1||-1|-1||-1||acute renal failure||10069339
-1||-1|-1||-1||electrocardiogram qtc interval prolonged||10014387
-1||-1|-1||-1||renal failure acute||10069339
-1||-1|-1||-1||renal adverse events||10062237
-1||-1|-1||-1||renal impairment||10062237
-1||-1|-1||-1||increased serum creatinine||10005483
-1||-1|-1||-1||renal insufficiency||10038435
-1||-1|-1||-1||renal failure||10038435
-1||-1|-1||-1||increases in serum creatinine||10005483
-1||-1|-1||-1||renal adverse event||10062237
-1||-1|-1||-1||hypersensitivity reactions||10020751
-1||-1|-1||-1||anaphylactic reactions||10002198
-1||-1|-1||-1||cross-reactivity||10076743
-1||-1|-1||-1||new onset renal impairment||10062237
-1||-1|-1||-1||worsening renal impairment||10062237
-1||-1|-1||-1||adverse developmental outcomes||10012559
-1||-1|-1||-1||fatal||10011906
-1||-1|-1||-1||colitis||10009887
-1||-1|-1||-1||interferes with laboratory coagulation tests||10063557
-1||-1|-1||-1||interferes with prothrombin time||10037057
-1||-1|-1||-1||interferes with international normalized ratio||10022592
-1||-1|-1||-1||interferes with activated partial thromboplastin time||10000631
-1||-1|-1||-1||qtc prolongation||10014387
-1||-1|-1||-1||interfered with tests to monitor coagulation||10063557
-1||-1|-1||-1||affected prothrombin time||10037057
-1||-1|-1||-1||affected international normalized ratio||10022592
-1||-1|-1||-1||affected activated partial thromboplastin time||10000631
-1||-1|-1||-1||affected activated clotting time||10009791
-1||-1|-1||-1||affected coagulation based factor x activity assay||10061774
-1||-1|-1||-1||prolonged the qtc interval||10014387
